Literature DB >> 15017648

Cholestatic jaundice as a paraneoplastic manifestation of prostate adenocarcinoma.

Apostolos Karakolios1, Christos Kasapis, Theofilos Kallinikidis, Panagiotis Kalpidis, Nikolaos Grigoriadis.   

Abstract

Malignancies may cause cholestatic jaundice through well-recognized mechanisms (e.g., bile duct obstruction or widespread hepatic infiltration). Paraneoplastic syndromes associated with malignancy, particularly with renal cell carcinoma (Stauffer's syndrome) and malignant lymphoproliferative diseases, can induce a reversible form of cholestasis through an unclear pathogenetic mechanism. Prostate cancer presenting initially with cholestatic jaundice without any obvious cause (i.e., obstruction or infiltration) has been reported in 2 cases in the medical literature. We report a patient who presented with pruritus and cholestatic jaundice. During the diagnostic work-up, prostate cancer was diagnosed. Conjugated bilirubin and alkaline phosphatase levels were increased markedly with modest increases of gamma-glutamyltranspeptidase and transaminase levels. The results of appropriate investigations performed during the patient's hospitalizations indicated no evidence of hepatic metastases or extrahepatic biliary obstruction. After treatment with flutamide and leuprolide, the patient's symptoms and the laboratory abnormalities reversed rapidly. We regard the cholestatic jaundice of this patient as part of a paraneoplastic syndrome; the cause of cholestasis remains an enigma. Patients with unexplained cholestasis should be investigated for malignancies, including prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15017648     DOI: 10.1016/s1542-3565(03)00227-1

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  15 in total

1.  Stauffer's syndrome variant with cholestatic jaundice: a case report.

Authors:  Diana Morla; Saleh Alazemi; Daniel Lichtstein
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

Review 2.  The investigation of unexplained biliary dilatation.

Authors:  Alan Coss; Robert Enns
Journal:  Curr Gastroenterol Rep       Date:  2009-04

3.  Idiopathic cholestatic jaundice may be a paraneoplastic manifestation of underlying malignancy: a case of prostate cancer.

Authors:  Akihiro Okano; Masaya Ohana; Fusako Kusumi
Journal:  Clin J Gastroenterol       Date:  2014-04-12

4.  Cholestatic Jaundice as a Paraneoplastic Manifestation of Prostate Cancer Aggravated by Steroid Therapy.

Authors:  Min Kyu Kang; Jung Gil Park; Heon Ju Lee
Journal:  Med Princ Pract       Date:  2018-01-10       Impact factor: 1.927

5.  Obstructive jaundice as a presenting symptom of metastatic carcinoma of the prostate.

Authors:  Arun Sahai; Chee Wan Lai; Gabriel Constantinescu; Mohamed Y Hammadeh
Journal:  BMJ Case Rep       Date:  2009-08-20

Review 6.  Paraneoplastic syndromes in prostate cancer.

Authors:  Matthew K Hong; Jennifer Kong; Benjamin Namdarian; Anthony Longano; Jeremy Grummet; Christopher M Hovens; Anthony J Costello; Niall M Corcoran
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

7.  Unusual causes of intrahepatic cholestatic liver disease.

Authors:  Elias E Mazokopakis; John A Papadakis; Diamantis P Kofteridis
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

Review 8.  Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling?

Authors:  Marine Baptissart; Aurelie Vega; Emmanuelle Martinot; Silvère Baron; Jean-Marc A Lobaccaro; David H Volle
Journal:  Cell Mol Life Sci       Date:  2013-06-20       Impact factor: 9.261

9.  Hepatic Dysfunction as a Paraneoplastic Manifestation of Metastatic Prostate Adenocarcinoma.

Authors:  David Kato; Chinemerem Okwara; Christopher Moreland; Allan Parker
Journal:  J Investig Med High Impact Case Rep       Date:  2014-06-24

10.  Cholestatic jaundice as a paraneoplastic manifestation of prostate cancer.

Authors:  Tomomi Kuramoto; Hiroya Senzaki; Hiroyuki Koike; Kenji Yamagiwa; Shinobu Tamura; Tokuzou Fujimoto; Takeshi Inagaki
Journal:  Case Rep Urol       Date:  2013-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.